Prochlorperazine Maleate Tablet
Product Images NDC 69452-472

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Maleate (NDC 69452-472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Image01)

This is a description of prochlorperazine maleate tablets, USP, with a strength of 5 mg. The usual dosage is between 10mg to 40mg daily. It is important to use precise dosing when dispensing this product as directed by a physician or requested by the purchaser. The tablets should be stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F). The product is distributed by BIONPHARMA and made in India. The package is child-resistant.*

FDA Label Image

Image002 (Image02)

This is a description for Prochlorperazine Maleate Tablets, USP. Each tablet contains Prochlorperazine maleate USP equivalent to Prochlorperazine 10mg. The usual dosage ranges from 10mg to 40mg daily. It is important to use a safety closure when dispensing this product unless otherwise directed by a physician or requested by the purchaser. The tablets should be stored at controlled room temperature between 15°C to 30°C (59°F to 86°F). These tablets are distributed by Bionpharma in Princeton, NJ and have been made in India. For complete prescribing information, one should refer to the accompanying package insert.*

FDA Label Image

Structure Of Prochlorperazine (Structure01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.